Veracyte, Inc. (VCYT) Analyst Forecast

NASDAQ Currency in USD Disclaimer

Add to Alerts ADD TO LIST

$0.00

$0 (0%)

Last update: 07:00 PM EST

Day's range

$32.73

$33.91

Recent Analyst Forecasts and Stock Ratings

Date	Brokerage Firm	Analyst Name	Price Target	Price when Posted	Upside/Downside on Report Date	Details
11/05/2026	Needham	Mike Matson	$46.00	$52.52	-12.41%
08/03/2026	Canaccord Genuity	Kyle Mikson	$50.00	$46.32	7.94%
07/31/2026	Needham	Mike Matson	$69.00	$59.78	15.42%
07/15/2026	Piper Sandler	David Westenberg	$66.00	$56.62	16.57%
06/29/2026	Guggenheim	Subbu Nambi	$65.00	$60.49	7.46%
06/01/2026	Needham	Mike Matson	$57.00	$48.38	17.81%
05/06/2026	Canaccord Genuity	Kyle Mikson	$42.00	$32.97	27.39%
03/05/2026	Morgan Stanley	Kallum Titchmarsh	$37.00	$34.68	6.69%
01/05/2026	Guggenheim	Subbu Nambi	$50.00	$42.95	16.43%
11/05/2025	UBS	Lu Li	$48.00	$43.64	9.99%
11/05/2025	Canaccord Genuity	Kyle Mikson	$43.00	$36.12	19.05%
10/20/2025	Canaccord Genuity	Kyle Mikson	$40.00	$35.83	11.64%
08/08/2025	Morgan Stanley	Tejas Savant	$28.00	$27.37	2.3%
11/07/2024	Needham	Mike Matson	$44.00	$35.85	22.74%
08/12/2024	Morgan Stanley	Tejas Savant	$26.00	$29.41	-11.58%

Veracyte Inc FAQ's

Veracyte Inc has been rated by research analysts at Needham, UBS, Morgan Stanley, Stephens, Piper Sandler, Canaccord Genuity in the past 90 days.